ABIO

ARCA biopharma, Inc.

1.96 USD

Last updated Nov 29, 11:51 UTC

Yesterday HIGH

$1.95

Yesterday LOW

$1.89

52w HIGH

$2.7

52w LOW

$1.74

EPS

-0.1

PE

-19.60

Next Earnings

Feb 23, 2024

Overview News Government Trades

ARCA biopharma, Inc. stock is up 8.89% since 30 days ago. The next earnings date is Feb 23, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 59.26% of the previous 26 November’s closed higher than October.

ARCA biopharma, Inc. develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 and Gencaro.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Westminster, United States Of America

Website

www.arcabiopharma.com

Benzinga Newsdesk

Wed Oct 18, 2023

ARCA biopharma Q3 EPS $(0.10) Up From $(0.16) YoY

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.10) per share. This is a 37.5 percent increase over losses of $(0.16) per share from the same period last year.
Benzinga Newsdesk

Fri Jul 21, 2023

ARCA biopharma Q2 EPS $(0.10) Up From $(0.22) YoY

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.10) per share. This is a 54.55 percent increase over losses of $(0.22) per share from the same period last year.
Happy Mohamed

Mon Apr 24, 2023

ARCA biopharma Q1 EPS $(0.09) Up From $(0.23) YoY

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.09) per share. This is a 60.87 percent increase over losses of $(0.23) per share from the same period last year.
Benzinga Newsdesk

Mon Feb 27, 2023

ARCA biopharma FY EPS $(0.69) Up From $(1.39) YoY; Cash & Cash Equivalents Of $42.4M Sufficient To Fund Its Operations Through The Middle Of 2024

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.69) per share. This is a 50.36 percent increase over losses of $(1.39) per share from the same period last year.
Michael Horton

Fri Oct 28, 2022

ARCA biopharma Q3 EPS $(0.16) Up From $(0.33) YoY

ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.16) per share. This is a 51.52 percent increase over losses of $(0.33) per share from the same period last year.